Precipio (NASDAQ:PRPO – Get Free Report) and Zhongchao (NASDAQ:ZCMD – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, valuation, risk, dividends, institutional ownership and profitability.
Analyst Ratings
This is a summary of recent ratings for Precipio and Zhongchao, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Precipio | 1 | 0 | 0 | 0 | 1.00 |
| Zhongchao | 1 | 0 | 0 | 0 | 1.00 |
Valuation & Earnings
This table compares Precipio and Zhongchao”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Precipio | $18.53 million | 2.51 | -$4.29 million | ($0.82) | -32.35 |
| Zhongchao | $15.86 million | 0.32 | -$640,000.00 | N/A | N/A |
Zhongchao has lower revenue, but higher earnings than Precipio.
Institutional and Insider Ownership
10.5% of Precipio shares are owned by institutional investors. Comparatively, 1.7% of Zhongchao shares are owned by institutional investors. 16.9% of Precipio shares are owned by insiders. Comparatively, 28.6% of Zhongchao shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Profitability
This table compares Precipio and Zhongchao’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Precipio | -5.50% | -10.07% | -6.71% |
| Zhongchao | N/A | N/A | N/A |
Summary
Zhongchao beats Precipio on 5 of the 8 factors compared between the two stocks.
About Precipio
Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels. It offers biomarker testing and clinical project services to bio-pharma customers. The company is based in New Haven, Connecticut.
About Zhongchao
Zhongchao Inc. provides healthcare information, education, and training services in the People's Republic of China. The company offers online and onsite health information services, healthcare education programs, and healthcare training products, including clinical practice training, open classes of popular medical topics, interactive case studies, academic conference and workshops, continuing education courses, and articles and short videos with educational healthcare content. It also provides customized medical courses and medical training services; and patient management services through online platform under the Zhongxun brand. The company operates through its mdmooc.org online platform under the MDMOOC brand; and Sunshine Health Forums, a Wechat subscription account and mobile app. It serves enterprises, non-for-profit organizations, and medical journals, as well as healthcare professionals, nurses, doctors, and other healthcare workers. The company was founded in 2012 and is headquartered in Shanghai, China.
Receive News & Ratings for Precipio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Precipio and related companies with MarketBeat.com's FREE daily email newsletter.
